Obesity and Hypertension
Related Articles
- Preface [Hot Topic: Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]. Lip, Gregory Y.H. // Current Pharmaceutical Design;Nov2004, Vol. 10 Issue 29, p1
This issue of Current Pharmaceutical Design, for which I have the honour to be Executive Guest Editor, addresses topical issues relating to the treatment of hypertension, its pathophysiology and the clinical use of antihypertensive drugs. Davis et al. [1] discusses antihypertensive drug...
- Microalbuminuria, Pulse Pressure, Left Ventricular Hypertrophy, and Myocardial Ultrasonic Tissue Characterization In Essential Hypertension. Bello, Vitantonio Di // Angiology;Mar2001, Vol. 52 Issue 3, p175
Analyzes the relationship among microalbuminuria, pulse pressure and left ventricular hypertrophy in hypertensive patients. Calculation of the cyclic variation index; Identification of abnormal texture in hypertension; Determination of myocardial alterations; Ultrasonic tissue characterization...
- Hypertension: Setting new goals for lower readings. Butler, Robert N.; August, Phyllis; Ferdinand, Keith C.; Phillips, Robert A.; Roccella, Edward J. // Geriatrics;Apr99, Vol. 54 Issue 4, p20
Presents the roundtable discussion of panelists about the primary care management of hypertension. Pathophysiology of hypertension; Prevalence of hypertension in the United States in general and among ethnic, racial and socioeconomic groups; Why hypertension control rate is low.
- Malignant Hypertension: Still a Problem in the Modern Anti-Hypertensive Era. Collidge, T.A.; Whitworth, C.E. // Current Medical Literature: Nephrology & Hypertension;2003, Vol. 9 Issue 3, p59
Presents an overview of developments in the understanding of malignant-phase hypertension (MH) and comments on its management. Pathophysiology of MH; Diagnosis and treatment; Risk factors and outcome predictors.
- Dysfunction of Cellular Transporters and Predisposition to Diabetic Nephropathy. Zerbini, Gianpaolo; Gabellini, Daniela; Ruggieri, Dora; Maestroni, Anna // Current Diabetes Reviews;2006, Vol. 2 Issue 2, p163
Diabetic nephropathy is presently the first reason of end stage renal failure in Europe and the USA and its worldwide prevalence is rapidly increasing. Several studies have demonstrated that diabetes per se is not sufficient to induce nephropathy and a genetic predisposition has to be present as...
- CITATIONS AND CLINICIANS' NOTES: HYPERTENSION -- COMPLICATIONS. // Current Medical Literature: Nephrology & Hypertension;2004, Vol. 10 Issue 3, p69
The article presents citations and clinicians' notes on the complications of hypertension. In a number of patients who are affected by advanced liver disease, portopulmonary hypertension and hepatopulmonary syndrome can occur, having a substantial impact on survival. These complications are...
- Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Uehata, Masayoshi; Ishizaki, Toshimasa // Nature;10/30/1997, Vol. 389 Issue 6654, p990
Presents research which showed that a pyridine derivative Y-27632 selectively inhibits smooth-muscle contraction by inhibiting Ca2+ sensitization. Abnormal smooth-muscle contractility; Regulation of smooth-muscle contraction; Role of small GTPase Rho and Rho-associated kinase; Y-27632 target a...
- FEMORO-FEMORAL VENOUS BY-PASS IN THE TREATMENT OF ACUTE VENOUS HYPERTENSION ASSOCIATED WITH FRACTURES OF THE FEMUR AND PELVIS. Hamer, John D.; Smith, J. E. M. // Vascular Surgery;Sep/Nov1974, Vol. 8 Issue 4, p228
Suggests a different indication for operating on the venous system in an injured limb. Decompression of the ilio-femoral venous segment in chronic venous occlusion; Pathophysiology of long-term venous occlusion and the sequelae of post-phlebitic syndrome; Administration of autogenous vein as...
- Antioxidative Protection in Hypertensive Patients Treated With Diuretics Skalska, Anna; Gąsowski, Jerzy; Stępniewski, Marek; Grodzicki, Tomasz // American Journal of Hypertension;Aug2005, Vol. 18 Issue 8, p1130
Background: Recently results of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) showed that a thiazide diuretic was unsurpassed by any other drug class studied in achieving the level of cardiovascular protection, a finding reflected in the recent Seventh...
